Cancer Research Audrey Hepburn  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 35-41, January 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tagliabue, A.
Right arrow Articles by McCoy, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tagliabue, A.
Right arrow Articles by McCoy, J. L.

Cellular Immunity to Tumor-associated Antigens of Transplantable Mammary Tumors of C3H/HeN Mice

Aldo Tagliabue1, Ronald B. Herberman, Larry O. Arthur and James L. McCoy

Laboratory of Immunodiagnosis, National Cancer Institute, NIH, Bethesda, Maryland 20014 [A. T., R. B. H., J. L. M.], and Viral Oncology Programs, National Cancer Institute, Frederick Cancer Research Center, Frederick, Maryland 21701 [L. O. A.]

Cellular immunity to tumor-associated antigens of C3H/HeN-MTV+ (hereafter called C3H+) and C3H/HeN-MTV-(hereafter called C3H-) mice bearing syngeneic transplantable mammary tumors was assessed by the production of migration inhibition factor in response to mouse mammary tumor virus (MTV)-related antigens or 3 M KCl tumor extracts, by the use of an indirect agarose microdroplet migration inhibition assay. C3H+ mice bearing a transplantable syngeneic mammary tumor (MAT-2) were generally unable to produce migration inhibition factor in response to MTV, whereas a strong immune response in those mice was elicited by a 3 M KCl extract of MAT-2 tumor. C3H-tumor-bearing mice were reactive to MTV as well as to 3 M KCl extract. The latter reactivity was found to be specific since these mice failed to react against similarly prepared 3 M KCl extracts of various normal or chemically induced tumor tissues. Two other spontaneously arising mammary tumors (MAT-3 and MAT-4) of C3H+ mice appeared to share an antigen with MAT-2. Furthermore, a 3 M KCl extract of C3H+ embryos, with no detectable MTV antigens, was found to stimulate migration inhibition reactivity in C3H+ and C3H- mice bearing MAT-2 tumor, which suggests that tumor growth induces reactivity against non-virus-related tumor-associated antigens, which are common to embryo cells. Induction of migration inhibition factor production by MAT-2 tumor-associated antigens or MTV appeared to be dependent on T-cells, since reactivity was eliminated by pretreatment of immune spleen cells with anti-Thy plus complement.

1 On leave from Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. To whom requests for reprints should be addressed, at Laboratory of Immunodiagnosis, National Cancer Institute, NIH, Building 10, Room 8B07, Bethesda, Md. 20014.

Received 3/ 2/78. Accepted 9/25/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.